v3.26.1
SCHEDULE OF CHANGES IN INVESTMENT (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Apr. 30, 2026
Apr. 30, 2025
Jul. 31, 2025
Restructuring Cost and Reserve [Line Items]          
Funding     $ 260,000 $ 255,000  
Share of losses $ (64,303) $ (62,738) (171,126) (176,837)  
BC Therapeutics Inc [Member]          
Restructuring Cost and Reserve [Line Items]          
Beginning balance     524,278 $ 418,490 $ 418,490
Funding     260,000   330,000
Share of losses     (171,126)   (224,212)
BC Therapeutics Option     193,829    
Change in fair value during the period     (55,999)    
Ending balance $ 750,982   $ 750,982   $ 524,278